Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials
Bessette L, Rudwaleit M, Brown M, van Gaalen F, Haroon N, Gensler L, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, et al. (2024)
Journal of Rheumatology 51(Suppl. 1): 67-68.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Bessette, Louis;
Rudwaleit, MartinUniBi;
Brown, Matthew;
van Gaalen, Floris;
Haroon, Nigil;
Gensler, Lianne;
Fleurinck, Carmen;
Marten, Alexander;
Massow, Ute;
de Peyrecave, Natasha;
Vaux, Thomas;
White, Katy
Alle
Alle
Einrichtung
Erscheinungsjahr
2024
Serien- oder Zeitschriftentitel
Journal of Rheumatology
Band
51
Ausgabe
Suppl. 1
Seite(n)
67-68
Konferenz
Annual Scientific Meeting of the Canadian-Rheumatology-Association (CRA)
Konferenzort
Winnipeg, Canada
Konferenzdatum
2024-02-28 – 2024-03-02
ISSN
0315-162X
eISSN
1499-2752
Page URI
https://pub.uni-bielefeld.de/record/2993104
Zitieren
Bessette L, Rudwaleit M, Brown M, et al. Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials. Journal of Rheumatology. 2024;51(Suppl. 1):67-68.
Bessette, L., Rudwaleit, M., Brown, M., van Gaalen, F., Haroon, N., Gensler, L., Fleurinck, C., et al. (2024). Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials. Journal of Rheumatology, 51(Suppl. 1), 67-68. https://doi.org/10.3899/jrheum.2024-0330_poster_presentations
Bessette, Louis, Rudwaleit, Martin, Brown, Matthew, van Gaalen, Floris, Haroon, Nigil, Gensler, Lianne, Fleurinck, Carmen, et al. 2024. “Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials”, Journal of Rheumatology, 51 (Suppl. 1): 67-68.
Bessette, L., Rudwaleit, M., Brown, M., van Gaalen, F., Haroon, N., Gensler, L., Fleurinck, C., Marten, A., Massow, U., de Peyrecave, N., et al. (2024). Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials. Journal of Rheumatology 51, 67-68.
Bessette, L., et al., 2024. Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials. Journal of Rheumatology, 51(Suppl. 1), p 67-68.
L. Bessette, et al., “Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials”, Journal of Rheumatology, vol. 51, 2024, pp. 67-68.
Bessette, L., Rudwaleit, M., Brown, M., van Gaalen, F., Haroon, N., Gensler, L., Fleurinck, C., Marten, A., Massow, U., de Peyrecave, N., Vaux, T., White, K., Deodhar, A., van der Horst-Bruinsma, I.: Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials. Journal of Rheumatology. 51, 67-68 (2024).
Bessette, Louis, Rudwaleit, Martin, Brown, Matthew, van Gaalen, Floris, Haroon, Nigil, Gensler, Lianne, Fleurinck, Carmen, Marten, Alexander, Massow, Ute, de Peyrecave, Natasha, Vaux, Thomas, White, Katy, Deodhar, Atul, and van der Horst-Bruinsma, Irene. “Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials”. Journal of Rheumatology 51.Suppl. 1 (2024): 67-68.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar